Risperdal Lawsuit


Risperdal Class Action FAQs

Risperdal Lawsuit Update

Audet and Partners, LLP is now representing several males who have been diagnosed with Gynecomastia after having taken the antipsychotic drug Risperdal.  If you have suffered this or a similar injury, you may be wondering whether you may have a valid claim for damages. The FAQs below are intended to better help you understand and assess how you might proceed in bringing a Risperdal lawsuit. (1) What is the basis for the current Risperdal lawsuits against Johnson & Johnson? For over a decade,... Read More

Risperdal Lawsuit $1.2 Billion Verdict Overturned by Arkansas Supreme Court

Risperdal Lawsuit News

On March 20, 2014, the Arkansas Supreme Court overturned a trial court award of $1.2 billion to the State of Arkansas against Johnson & Johnson, and its Janssen Pharmaceuticals, Inc. division based on the company's marketing of the antipsychotic frog Risperdal.  This Arkansas lawsuit had been brought by the Arkansas Attorney General and relied on a provision of Arkansas state law governing Medicaid fraud as a basis to challenge the marketing of Risperdal in Arkansas which allegedly included misleading claims... Read More

Risperdal Lawsuit Settlement Costs Johnson & Johnson $5.9 Million

Risperdal Lawsuits

Janssen Pharmaceutical, Inc., the division of Johnson & Johnson that developed and marketed the Risperdal antipsychotic medication, has settled a Risperdal lawsuit brought by the State of Montana for $5.9 million.  The Attorney General of Montana had initiated a lawsuit against the manufacturer in 2008 alleging that the company promoted the drug as safe despite having knowledge of a range of dangerous side effects, including diabetes. The settlement terms require Johnson & Johnson to cease any misleading marketing of Risperdal, and... Read More